Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis
Open Access
- 1 May 1992
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 102 (5) , 1620-1627
- https://doi.org/10.1016/0016-5085(92)91722-g
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.Gut, 1990
- Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies.The Journal of Experimental Medicine, 1990
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- The role of interleukin 2 in autoimmunityImmunology Today, 1989
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.Journal of Clinical Investigation, 1986
- Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.Journal of Clinical Investigation, 1985
- Recent Developments in Nonspecific Inflammatory Bowel DiseaseNew England Journal of Medicine, 1982
- Recent Developments in Nonspecific Inflammatory Bowel DiseaseNew England Journal of Medicine, 1982
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980